Gelteq (GELS) Retained Earnings (2023 - 2025)
Gelteq (GELS) recorded quarterly Retained Earnings of -$11.6 million in Q2 2025, down 20.04% quarter-over-quarter from -$9.7 million in Q4 2024, and down 53.36% on a YoY basis from -$24.9 million in Q2 2024.
Gelteq (GELS) Retained Earnings (2023 - 2025) Analysis & Trends
Gelteq's Retained Earnings history runs 3 years deep, the most recent figure standing at -$11.6 million for Q2 2025.
- In Q2 2025, Retained Earnings fell 53.36% year-over-year to -$11.6 million; the TTM figure through Jun 2025 stood at -$11.6 million (down 53.36% YoY), while the FY2025 annual figure was -$11.6 million, down 53.36% from the prior year.
- Retained Earnings was -$11.6 million for Q2 2025 at Gelteq, down from -$9.7 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$5.3 million in Q2 2023 to a low of -$11.6 million in Q2 2025.
- Historically, Retained Earnings has averaged -$8.5 million across 3 years, with a median of -$8.6 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings sank 42.59% in 2024, then sank 53.36% in 2025.
- A 3-year view of Retained Earnings shows it stood at -$5.3 million in 2023, then plunged by 82.16% to -$9.7 million in 2024, then decreased by 20.04% to -$11.6 million in 2025.
- The last three Retained Earnings figures came in at -$11.6 million (Q2 2025), -$9.7 million (Q4 2024), and -$7.6 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Gelteq | 10.57 Mn | 10.34 Mn | - | -11.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -11.62 Mn |
| Dec 31, 2024 | -9.68 Mn |
| Jun 30, 2024 | -7.58 Mn |
| Jun 30, 2023 | -5.31 Mn |